Dr. Cuneo performs preclinical and translation research in gastrointestinal malignancies. His laboratory research focuses on identifying and testing novel radiation sensitizers for hepatocellular carcinoma. Dr. Cuneo is also involved in translational studies related to biomarker discovery in pancreatic cancer. He is examining the use of diffusion weighted MRI, circulating tumor cells, and tumor derived exosomes as early treatment response markers.